Although not widely availble when this trial was initiated in 1978, endoscopic treatment (sclerosis and banding) has become the mainstay in most centers for management of the acute variceal bleeder with bleeding control rates in excess of 70% in nearly all series [4, 5, 6] . Additionally, other effective non-operative therapies such as transjugular intrahepatic portosystemic shunt (TIPS) [7] and intravenous octreotide [4, 8] [7] . Clinical and biochemical data were recorded in each patient, and the severity of the liver disease was assessed using the Cambell numeral modification of Child's grading [13] .
The following portal hemodynamic parameters were evaluated in the 87 (19% more) by the Congestion Index. However, the identification of patients with late occurrence of bleeding (after 6 months from entry) was poor in both models, with or without the inclusion of the Congestion Index (45 vs. 50%).
In conclusion, the study of Siringo et al. [5] shows, that a subgroup of cirrhotic patients is at a high risk of bleeding within 6 months of entry into the study. This (2) . However, the criteria described by our group [9] are more reliable.
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